
The zzso zzso zzso zzso is an attractive therapeutic target in breast cancer because it plays key roles in invasion and zzso While its inactive form is widely zzso activated zzso occurs only on tumor cells and their associated zzso The zzso zzso has been shown to bind activated zzso zzso thereby blocking invasion in zzso and zzso growth, zzso and tumor recurrence in zzso zzso zzso in a recent Phase I clinical trial, systemic zzso zzso was well zzso and zzso disease failed to progress for zzso months in 38% of patients receiving zzso A significantly more potent zzso zzso the zzso zzso zzso has recently been zzso We report that it is zzso to zzso more potent than the zzso zzso at blocking zzso zzso zzso zzso and zzso human breast cancer cell invasion of naturally occurring basement zzso in zzso zzso analysis of these data suggested that invasion zzso by the zzso zzso was highly zzso We also report that, consistent with its enhanced zzso zzso the zzso zzso is zzso to zzso more effective than the zzso zzso at preventing zzso zzso and zzso zzso in the lungs of zzso nude zzso Our results also show that many zzso zzso zzso and zzso cells go on to develop into zzso zzso and that zzso with the zzso zzso is more than zzso more effective at reducing lung colony zzso Since many patients newly diagnosed with breast cancer already have locally advanced or zzso disease, the availability of a zzso nontoxic systemic therapy that can prevent zzso progression by blocking invasion could be very zzso 

